Riskpilot← Back to searchSign inGet full accessMaternify ApS
APSActiveCVR 42232645Duevej 11Research and experimental development on natural sciences and engineering · NACE 7210Est. 20211 employeesflexbureau.dk
Revenue 2025
DKK -45K
-58% vs 2024
EBITDA margin
100.0%
+58% vs 2024
Equity ratio
70.6%
Financial strength
Net profit 2025
DKK -49K
+60% vs 2024
| Revenue | DKK -45K | -58% |
| EBITDA | DKK -45K | +58% |
| Net profit | DKK -49K | +60% |
| Total assets | DKK 1,8M | +6270% |
| Equity | DKK 1,3M | +5256% |
| Employees | 1 | — |
Legal name
Maternify ApS
CVR number
42232645
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28. februar 2021
Share capital
DKK 40.002
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af to medlemmer af direktionen
Company purpose
Virksomhedens primære formål er at udvikle og tilbyde innovative løsninger inden for fertilitet, graviditet og relaterede sundhedsområder. Eventuelle sekundære aktiviteter, der understøtter dette formål, skal være i overensstemmelse med virksomhedens kerneværdier og vision
Address
Duevej 11
Phone
+4526297972
Email
flexbureauaps@gmail.com
Website
flexbureau.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 359 | 1.589 | 211 | -109 | -45 |
| Staff expenses | -228 | -1.394 | -139 | -0 | -0 |
| EBITDA | 131 | 195 | 72 | -109 | -45 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 131 | 195 | 72 | -109 | -45 |
| Net financials | -1 | -4 | 0 | -12 | -3 |
| Profit before tax | 129 | 191 | 72 | -121 | -49 |
| Tax | 29 | 42 | 17 | -0 | -0 |
| Net profit | 100 | 149 | 56 | -121 | -49 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 497 | 479 | 207 | 28 | 1.805 |
| Equity | 140 | 289 | 145 | 24 | 1.275 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 356 | 190 | 62 | 5 | 530 |
| Total debt | 356 | 190 | 62 | 5 | 530 |
EBITDA margin
-4523100.0%
This company
15.8%
Market median
-28627315% vs market
20212025
Equity ratio
70.6%
This company
38.2%
Market median
+85% vs market
20212025
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
20212025
Net profit margin
-4850600.0%
This company
8.1%
Market median
-59884051% vs market
20212025
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20212025
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via CVR / Virk · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-10-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-02-28 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NH Founder | Founder | 2021 |
PN Management | Management | 2021 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2023 | |
| Company | 10–14.99% | 10–14.99% | 2024 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2021 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Butler Investments ApS
Maternify ApS Board members of Maternify ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nasseh Hashemi | Founder | 0 companies |
| Patrick Nyborg Butler | Management | 0 companies |